- Accepting New Patients
- Telehealth Visits
Lela Bachrach, MD, MS
Adolescent Medicine- Accepting New Patients
- Telehealth Visits
Lela Bachrach, MD, MS
Adolescent Medicine- Accepting New Patients
- Telehealth Visits
On this page
About me
Dr. Lela Bachrach is a pediatrician who specializes in caring for adolescents. She has a particular focus on improving access to reproductive health care for teenagers. She enjoys helping patients optimize their health so they can focus on achieving their goals and dreams.
Bachrach leads a multidisciplinary professional group dedicated to addressing intimate partner violence and ending human trafficking. The team supports survivors from a trauma-informed, public health perspective. She is also active in expanding health education services for adolescents at school-based health centers and partner community-based organizations.
Bachrach earned both her medical degree and master's degree in health and medical sciences via the UC Berkeley-UCSF Joint Medical Program (JMP). She completed a residency in pediatrics in UCSF's PLUS program: Pediatric Leaders Advancing Health Equity.
Education
Board Certification
- Pediatrics, American Board of Pediatrics
School
- MD, UCSF School of Medicine
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Adolescent Medicine
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Clinical trials
Health-E You Efficacy Trial for Male AdolescentsOpens in a new window
Recruiting
Higher score indicates greater self-efficacy for correct use of male condoms. This measure is scaled with range from 1 (very difficult) to 5 (very easy); range...
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.